Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Cools

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Blood|September 7, 2014
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse modelSandrine Degryse, Charles E de Bock, Luk Cox, et al.
International Journal of Cancer|August 21, 2013
Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcomaBarbara Dewaele, Joanna Przybyl, Anna Quattrone, et al.
Blood|July 21, 2005
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivoElizabeth H Stover, Jing Chen, Benjamin H Lee, et al.
Genes, Chromosomes & Cancer|February 7, 2016
Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignanciesKatrien Van Roosbroeck, Julio Finalet Ferreiro, Thomas Tousseyn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic LeukemiaDelphine Verbeke, Sofie Demeyer, Cristina Prieto, et al.
Plos One|July 25, 2014
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphomaJulio Finalet Ferreiro, Leila Rouhigharabaei, Helena Urbankova, et al.
Molecular Cancer Therapeutics|July 11, 2007
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cellsEllen Weisberg, Andrew L Kung, Renee D Wright, et al.
JCI Insight|June 2, 2017
Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomasJoanna Przybyl, Magdalena Kowalewska, Anna Quattrone, et al.
Plos Biology|February 27, 2009
Atonal homolog 1 is a tumor suppressor geneWouter Bossuyt, Avedis Kazanjian, Natalie De Geest, et al.
Nature Communications|June 18, 2021
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specifiedKoen Debackere, Lukas Marcelis, Sofie Demeyer, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Blood|September 7, 2014
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse modelSandrine Degryse, Charles E de Bock, Luk Cox, et al.
International Journal of Cancer|August 21, 2013
Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcomaBarbara Dewaele, Joanna Przybyl, Anna Quattrone, et al.
Blood|July 21, 2005
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivoElizabeth H Stover, Jing Chen, Benjamin H Lee, et al.
Genes, Chromosomes & Cancer|February 7, 2016
Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignanciesKatrien Van Roosbroeck, Julio Finalet Ferreiro, Thomas Tousseyn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic LeukemiaDelphine Verbeke, Sofie Demeyer, Cristina Prieto, et al.
Plos One|July 25, 2014
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphomaJulio Finalet Ferreiro, Leila Rouhigharabaei, Helena Urbankova, et al.
Molecular Cancer Therapeutics|July 11, 2007
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cellsEllen Weisberg, Andrew L Kung, Renee D Wright, et al.
JCI Insight|June 2, 2017
Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomasJoanna Przybyl, Magdalena Kowalewska, Anna Quattrone, et al.
Plos Biology|February 27, 2009
Atonal homolog 1 is a tumor suppressor geneWouter Bossuyt, Avedis Kazanjian, Natalie De Geest, et al.
Nature Communications|June 18, 2021
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specifiedKoen Debackere, Lukas Marcelis, Sofie Demeyer, et al.
Pageof 19